Publication | Open Access
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
308
Citations
135
References
2011
Year
GastroenterologyPathologySurgeryEndoscopic UltrasoundEndoscopic ImagingColonoscopyRadiologyHealth SciencesMedical ImagingMedicineGi TechniqueUltrasoundLung CancerEndoscopic DiagnosisClinical GuidelineEndoscopyInterventional Endoscopic UltrasoundEus-guided GastroenterostomyEus-guided Trucut BiopsyGastrointestinal PathologyInterventional EndoscopyOncology
ESGE’s guideline reviews EUS‑guided sampling (FNA and trucut biopsy) for a wide range of gastrointestinal and mediastinal lesions, addresses issues such as false‑positive cytology and needle‑tract seeding, and targets gastroenterologists, oncologists, internists, surgeons, and endoscopists. The guideline aims to describe the results of EUS‑guided sampling across clinical settings, evaluate its role in patient management, and recommend when to use the technique. It provides a two‑page executive summary of evidence statements and recommendations, and a separate technical guideline detailing the general technique, lesion‑specific sampling strategies, and sample processing to maximize diagnostic yield. The guideline reports that EUS‑guided sampling yields clinically useful results in diverse settings and offers evidence‑based recommendations for its appropriate use.
This article is part of a combined publication that expresses the current view of the European Society of Gastrointestinal Endoscopy (ESGE) about endoscopic ultrasound (EUS)-guided sampling in gastroenterology, including EUS-guided fine needle aspiration (EUS-FNA) and EUS-guided trucut biopsy (EUS-TCB), of submucosal tumors, diffuse esophageal/gastric wall thickening, pancreatic solid masses and cystic-appearing lesions, mediastinal lesions unrelated to lung or esophageal cancer, cancer of the esophagus, stomach, and rectum, lymph nodes of unknown origin, adrenal gland masses, and focal liver lesions. False-positive cytopathological results and needle tract seeding are also discussed. The present Clinical Guideline describes the results of EUS-guided sampling in the different clinical settings, considers the role of this technique in patient management, and makes recommendations on circumstances that warrant its use. A two-page executive summary of evidence statements and recommendations is provided. A separate Technical Guideline describes the general technique of EUS-guided sampling, particular techniques to maximize the diagnostic yield depending on the nature of the target lesion, and sample processing. The target readership for the Clinical Guideline mostly includes gastroenterologists, oncologists, internists, and surgeons while the Technical Guideline should be most useful to endoscopists who perform EUS-guided sampling.
| Year | Citations | |
|---|---|---|
Page 1
Page 1